Bottom line
How much do PHSYX and FHLC overlap?
67% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 65.4% of PHSYX's assets and 58.9% of FHLC's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 115), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PHSYX and FHLC have in common
| Holding | % of PHSYX | % of FHLC | Overlap |
|---|---|---|---|
| Eli Lilly & Co. | 13.15% | 13.35% | 13.15% |
| Johnson & Johnson | 8.46% | 8.93% | 8.46% |
| UnitedHealth Group, Inc. | 6.93% | 5.44% | 5.44% |
| AbbVie, Inc. | 6.05% | 6.42% | 6.05% |
| Merck & Co., Inc. | 4.88% | 4.66% | 4.66% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.09% | 3.09% |
| Intuitive Surgical, Inc. | 4.04% | 1.82% | 1.82% |
| CVS Health Corp. | 2.74% | 1.92% | 1.92% |
| Gilead Sciences, Inc. | 2.63% | 2.34% | 2.34% |
| McKesson Corp. | 2.14% | 1.52% | 1.52% |
| Cardinal Health, Inc. | 2.12% | 0.78% | 0.78% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 1.76% | 1.76% |
| Boston Scientific Corp. | 1.80% | 1.00% | 1.00% |
| Bristol-Myers Squibb Co. | 1.75% | 1.93% | 1.75% |
| HCA Healthcare, Inc. | 1.18% | 0.91% | 0.91% |
| Amgen, Inc. | 1.11% | 3.00% | 1.11% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PHSYX
- Novartis AG — 5.13%
- AstraZeneca plc — 4.67%
- Sanofi SA — 3.23%
- Edwards Lifesciences Corp. — 2.80%
- Roche Holding AG — 2.79%
- Novo Nordisk A/S — 1.90%
- Dexcom, Inc. — 1.64%
- Hoya Corp. — 1.52%
- Putnam Short Term Investment Fund — 1.35%
Only in FHLC
- Abbott Laboratories — 2.66%
- Pfizer Inc — 2.06%
- Danaher Corp — 1.80%
- Stryker Corp — 1.62%
- Medtronic PLC — 1.59%
- Elevance Health Inc — 1.19%
- Regeneron Pharmaceuticals Inc — 1.15%
- Cigna Group/The — 1.06%
- Cencora Inc — 0.83%
Asset mix
| Asset type | PHSYX | FHLC |
|---|---|---|
| Stocks | 98.2% | 99.7% |
| Other | 1.4% | — |
| Cash & short-term funds | 0.6% | 0.2% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | PHSYX | FHLC |
|---|---|---|
| US | 76.2% | 96.5% |
| CH | 7.9% | 0.1% |
| GB | 6.4% | 0.5% |
| FR | 3.2% | — |
| DK | 2.4% | — |
| JP | 2.4% | — |
| IE | — | 2.2% |
| NL | 1.2% | 0.1% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PHSYX and FHLC overlap?
What stocks do PHSYX and FHLC have in common?
Should I own both PHSYX and FHLC?
Which holds more stocks, PHSYX or FHLC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.